Nebula Research & Development’s Select Medical SEM Stock Holding History

Nebula Research & Development’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-112,364	Closed	-$1.71M	–	739
2025 Q2	$1.71M	Buy	+112,364	New	+$1.75M	0.15%	232
2024 Q4	–	Sell	-13,829	Closed	-$260K	–	1082
2024 Q3	$260K	Sell	13,829 -17,148	-55%	-$329K	0.03%	759
2024 Q2	$585K	Sell	30,977 -7,036	-19%	-$120K	0.09%	381
2024 Q1	$618K	Sell	38,013 -12,797	-25%	-$187K	0.13%	290
2023 Q4	$643K	Buy	+50,810	New	+$641K	0.19%	166
2023 Q2	–	Sell	-23,092	Closed	-$322K	–	439
2023 Q1	$322K	Buy	+23,092	New	+$340K	0.57%	16

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nebula Research & Development's SEM Position: Q3 2025 in Review

Nebula Research & Development sold out of Select Medical (SEM) in Q3 2025, closing a stake of 112,364 shares — an estimated $1.71M sold.

Nebula Research & Development first reported a position in SEM in Q1 2023 and held it in 6 quarters. The position peaked at $1.71M in Q2 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

Nebula Research & Development reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
Nebula Research & Development sold 112,364 Select Medical shares in Q3 2025, an estimated $1.71M.
Nebula Research & Development first reported a position in Select Medical in Q1 2023 and held it in 6 quarters.
Nebula Research & Development's Select Medical position peaked at $1.71M in Q2 2025.
268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.